Abbott Laboratories shares owned by Contravisory Investment Management
Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Contravisory Investment Management
from 13F filings
Historical chart of Contravisory Investment Management investment in Abbott Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Abbott Laboratories held by Contravisory Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Abbott Laboratories by Contravisory Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 7.9k | 133.94 |
| 2025-06-30 | $631k | 4.6k | 136.01 |
| 2025-03-31 | $609k | 4.6k | 132.65 |
| 2023-03-31 | $66k | 650 | 101.26 |
| 2022-12-31 | $71k | 650 | 109.79 |
| 2022-09-30 | $365k | 3.8k | 96.71 |
| 2022-06-30 | $423k | 3.9k | 108.68 |
| 2022-03-31 | $471k | 4.0k | 118.31 |
| 2021-12-31 | $622k | 4.4k | 140.82 |
| 2021-09-30 | $469k | 4.0k | 118.23 |
| 2021-06-30 | $7.3M | 63k | 115.93 |
| 2021-03-31 | $7.7M | 64k | 119.83 |
| 2020-12-31 | $7.3M | 67k | 109.49 |
| 2020-09-30 | $7.2M | 66k | 108.83 |
| 2020-06-30 | $5.9M | 66k | 89.74 |
| 2020-03-31 | $5.1M | 64k | 78.90 |
| 2019-12-31 | $5.7M | 66k | 86.86 |
| 2019-09-30 | $5.4M | 65k | 83.67 |
| 2019-06-30 | $5.5M | 65k | 84.11 |
| 2019-03-31 | $5.5M | 69k | 79.94 |
| 2018-12-31 | $5.2M | 72k | 72.33 |
| 2018-09-30 | $5.3M | 72k | 73.36 |
| 2018-06-30 | $4.6M | 75k | 60.99 |
| 2018-03-31 | $55k | 917 | 59.98 |
| 2017-12-31 | $52k | 917 | 56.71 |
| 2017-09-30 | $49k | 917 | 53.44 |
| 2015-12-31 | $2.0k | 48 | 41.67 |
| 2013-06-30 | $5.7M | 164k | 34.88 |
| 2013-03-31 | $5.5M | 156k | 35.32 |
| 2012-12-31 | $10M | 155k | 65.50 |
| 2012-09-30 | $11M | 159k | 68.56 |
| 2012-06-30 | $11M | 173k | 64.47 |
| 2012-03-31 | $11M | 174k | 61.29 |
| 2011-12-31 | $621k | 11k | 56.23 |
More positions owned by Contravisory Investment Management
View all positions for Contravisory Investment Management